Articles published in Journal of Diabetic Complications & Medicine have been cited by esteemed scholars and scientists all around the world.
Journal of Diabetic Complications & Medicine has got h-index 6, which means every article in Journal of Diabetic Complications & Medicine has got 6 average citations.
Following are the list of articles that have cited the articles published in Journal of Diabetic Complications & Medicine.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
Total published articles |
40 | 25 | 32 | 30 | 23 | 3 | 6 |
Research, Review articles and Editorials |
4 | 1 | 2 | 7 | 17 | 0 | 6 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
36 | 24 | 30 | 23 | 6 | 0 | 0 |
Conference proceedings |
0 | 15 | 51 | 23 | 0 | 15 | 37 |
Citations received as per Google Scholar, other indexing platforms and portals |
127 | 89 | 16 | 18 | 13 | 13 | 7 |
| Journal total citations count | 102 |
| Journal impact factor | 2.05 |
| Journal 5 years impact factor | 0.74 |
| Journal cite score | 2.71 |
| Journal h-index | 6 |
| Journal h-index since 2019 | 4 |
Insulin Resistance Is Associated with Impaired Nitric Oxide Synthase Activity in Skeletal Muscle of Type 2 Diabetic Subjects |
|
Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial. |
|
Effects of Bariatric Surgery on Glucose Homeostasis and Type 2 Diabetes |
|
Factors associated with good glycemic control among patients with type 2 diabetes mellitus |
|
Therapeutic potential of ?-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review |
|
Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin |
|
Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses |
|
Efficacy of Glyburide/Metformin Tablets Compared with Initial Monotherapy in Type 2 Diabetes |
|
Effects of peroxisome proliferator-activated receptor (PPAR)-? and PPAR-? agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus |
|
Weight Effect of Current and Experimental Drugs for Diabetes Mellitus |
|
Inhibition of Net HepG2 Cell Apolipoprotein B Secretion by the Citrus Flavonoid Naringenin Involves Activation of Phosphatidylinositol 3-Kinase, Independent of Insulin Receptor Substrate-1 Phosphorylation |
|
Caring for Poorly Controlled Diabetes Mellitus: A Randomized Pharmacist Intervention |
|
The importance of insulin resistance in polycystic ovary syndrome |
|
Diabesity: therapeutic options |
|
Regulation of Glucose Transport and Insulin Signaling by Troglitazone or Metformin in Adipose Tissue of Type 2 Diabetic Subjects |
|
Bariatric surgery: effects on glucose homeostasis |
|
Anti-diabetic effects of brown algae derived phlorotannins, marine polyphenols through diverse mechanisms |
|
Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study |
|
Incretin-Based Therapies Viewpoints on the way to consensus |
|
Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes |
|
Journal of Diabetic Complications & Medicine received 102 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 